CompletedPhase 2NCT03011580

Vitamin D to Resolve Inflammation After Tuberculosis (ResolveD-TB)

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Queen Mary University of London
Principal Investigator
Adrian Martineau, Prof
Barts and The London School of Medicine and Dentistry, Queen Mary University, University of London
Intervention
Fultium-D3(dietary_supplement)
Enrollment
15 enrolled
Eligibility
20 years · All sexes
Timeline
2017 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03011580 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials